Walter Blane 4
4 · HELIUS MEDICAL TECHNOLOGIES, INC. · Filed Nov 20, 2017
Insider Transaction Report
Form 4
Walter Blane
Director
Transactions
- Purchase
Class A Common Stock
2017-11-16$2.40/sh+20,000$48,090→ 20,000 total - Purchase
Class A Common Stock
2017-11-17$2.51/sh+20,000$50,250→ 40,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.35 - $2.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.40- $2.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.